The Rise of Peptide Therapy: Trends, Legality, and User Experiences

Peptide therapy is gaining traction among biohackers, celebrities, and wellness enthusiasts, who seek benefits such as improved energy, weight loss, and enhanced recovery from injuries. Peptides, which are chains of amino acids, function as messengers in the body, influencing various essential processes including metabolism, immune function, and muscle growth. Popular peptides like GHK-CU, BPC-157, and TB-500 are frequently discussed on social media platforms, particularly TikTok, where users share their experiences and results. Despite their popularity, many of these therapies lack approval from the United States Food and Drug Administration (FDA), raising questions about their safety and legality.

The New Zealand Herald

In New Zealand, the legal status of peptides is complex. While some peptides can be obtained via prescription, many local sellers exploit a loophole that allows them to market peptides for "research purposes only." This classification enables suppliers to sell peptides without the stringent oversight required for approved medications. Medsafe, New Zealand's regulatory authority, has warned against the purchase of peptides without a prescription, emphasizing the risks associated with unregulated products. In December 2025, ten peptides were classified as prescription medicines, but Medsafe continues to caution against the importation of non-prescribed peptides, which can lead to serious health risks, including infections and allergic reactions.

The New Zealand Herald

Personal accounts from users highlight both the potential benefits and risks of peptide therapy. Celine Wallace, an Ayurvedic medicine practitioner, began using peptides after witnessing positive changes in a friend. She reported significant improvements in her energy levels and skin appearance after incorporating peptides like NAD+ and GHK-CU into her routine. Similarly, Sarah Smith, a registered nurse, noted enhanced athletic performance and skin radiance after using BPC-157 and TB-500. However, Smith also shared her negative experience with Melanotan II, which caused unwanted skin changes, prompting her to discontinue its use.

The New Zealand Herald

Despite the enthusiasm surrounding peptide therapy, there are significant concerns regarding self-diagnosis and self-prescription. Smith expressed apprehension about the lack of regulation in peptide sales, stating, “Just because you want to take CJC-1295, is there something going on in your body that would mean it’s not right for you?” This sentiment reflects a broader concern about the safety and efficacy of peptides, particularly when sourced from unverified suppliers.

The New Zealand Herald

Medsafe has reiterated its position on the risks associated with non-prescribed peptides, stating, “There is very little known about any potential benefits or harms from their use.” The agency emphasizes that the sale of peptides intended for therapeutic purposes without a prescription violates the Medicines Act 1981, and any imported peptides without a prescription are subject to seizure and destruction.

The New Zealand Herald

As peptide therapy continues to rise in popularity, the interplay between user experiences, regulatory challenges, and safety concerns remains critical. While some users report transformative effects, the lack of oversight and potential health risks necessitate caution. The future of peptide therapy in New Zealand will likely depend on evolving regulations and increased awareness of the implications of self-prescribing.

The New Zealand Herald